---
title: "Iloprost - Pulmonary arterial hypertension"
sidebar: mydoc_sidebar
permalink: db01088-mesh-d000081029-1.html
toc: false 
---


Path ID: `DB01088_MESH_D000081029_1`
{% include image.html url="images/db01088-mesh-d000081029-1.png" file="db01088-mesh-d000081029-1.png" alt="db01088-mesh-d000081029-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D016285 | iloprost | Drug |
| UniProt:P43119 | Prostacyclin receptor | Protein |
| UniProt:P34995 | Prostaglandin E2 receptor EP1 subtype | Protein |
| UniProt:P43116 | Prostaglandin E2 receptor EP2 subtype | Protein |
| UniProt:P35408 | Prostaglandin E2 receptor EP4 subtype | Protein |
| UniProt:Q9Y5Y4 | Prostaglandin D2 receptor 2 | Protein |
| MESH:D002118 | Calcium | ChemicalSubstance |
| GO:0044557 | relaxation of smooth muscle | BiologicalProcess |
| GO:0042311 | vasodilation | BiologicalProcess |
| MESH:D000081029 | Pulmonary arterial hypertension | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Iloprost | INCREASES ACTIVITY OF | Prostacyclin Receptor |
| Iloprost | INCREASES ACTIVITY OF | Prostaglandin E2 Receptor Ep1 Subtype |
| Iloprost | INCREASES ACTIVITY OF | Prostaglandin E2 Receptor Ep2 Subtype |
| Iloprost | INCREASES ACTIVITY OF | Prostaglandin E2 Receptor Ep4 Subtype |
| Iloprost | INCREASES ACTIVITY OF | Prostaglandin D2 Receptor 2 |
| Prostaglandin E2 Receptor Ep1 Subtype | DECREASES ABUNDANCE OF | Calcium |
| Prostaglandin E2 Receptor Ep2 Subtype | DECREASES ABUNDANCE OF | Calcium |
| Prostaglandin D2 Receptor 2 | DECREASES ABUNDANCE OF | Calcium |
| Prostaglandin E2 Receptor Ep4 Subtype | DECREASES ABUNDANCE OF | Calcium |
| Prostacyclin Receptor | DECREASES ABUNDANCE OF | Calcium |
| Calcium | NEGATIVELY CORRELATED WITH | Relaxation Of Smooth Muscle |
| Relaxation Of Smooth Muscle | POSITIVELY CORRELATED WITH | Vasodilation |
| Vasodilation | NEGATIVELY CORRELATED WITH | Pulmonary Arterial Hypertension |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01088#BE0000475](https://go.drugbank.com/drugs/DB01088#BE0000475)
  - [https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology](https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology)
  - [https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms](https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms)
  - [https://en.wikipedia.org/wiki/Prostacyclin#Mechanism](https://en.wikipedia.org/wiki/Prostacyclin#Mechanism)
  - [https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics](https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics)

Reference: 
  - [https://go.drugbank.com/drugs/DB01088#BE0000475](https://go.drugbank.com/drugs/DB01088#BE0000475)
  - [https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology](https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology)
  - [https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms](https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms)
  - [https://en.wikipedia.org/wiki/Prostacyclin#Mechanism](https://en.wikipedia.org/wiki/Prostacyclin#Mechanism)
  - [https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics](https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics)

Reference: 
  - [https://go.drugbank.com/drugs/DB01088#BE0000475](https://go.drugbank.com/drugs/DB01088#BE0000475)
  - [https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology](https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology)
  - [https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms](https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms)
  - [https://en.wikipedia.org/wiki/Prostacyclin#Mechanism](https://en.wikipedia.org/wiki/Prostacyclin#Mechanism)
  - [https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics](https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics)

Reference: 
  - [https://go.drugbank.com/drugs/DB01088#BE0000475](https://go.drugbank.com/drugs/DB01088#BE0000475)
  - [https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology](https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology)
  - [https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms](https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms)
  - [https://en.wikipedia.org/wiki/Prostacyclin#Mechanism](https://en.wikipedia.org/wiki/Prostacyclin#Mechanism)
  - [https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics](https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics)

Reference: 
  - [https://go.drugbank.com/drugs/DB01088#BE0000475](https://go.drugbank.com/drugs/DB01088#BE0000475)
  - [https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology](https://en.wikipedia.org/wiki/Iloprost#Clinical_pharmacology)
  - [https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms](https://en.wikipedia.org/wiki/Vasodilation#Examples_and_individual_mechanisms)
  - [https://en.wikipedia.org/wiki/Prostacyclin#Mechanism](https://en.wikipedia.org/wiki/Prostacyclin#Mechanism)
  - [https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics](https://en.wikipedia.org/wiki/Prostaglandin_EP3_receptor#Therapeutics)
